PL3825695T3 - Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AIT - Google Patents
Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AITInfo
- Publication number
- PL3825695T3 PL3825695T3 PL20200807.4T PL20200807T PL3825695T3 PL 3825695 T3 PL3825695 T3 PL 3825695T3 PL 20200807 T PL20200807 T PL 20200807T PL 3825695 T3 PL3825695 T3 PL 3825695T3
- Authority
- PL
- Poland
- Prior art keywords
- ait
- responders
- biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/521—Chemokines
- G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19211257 | 2019-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3825695T3 true PL3825695T3 (pl) | 2024-04-22 |
Family
ID=68655405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20200807.4T PL3825695T3 (pl) | 2019-11-25 | 2020-10-08 | Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AIT |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3825695B1 (pl) |
| ES (1) | ES2972035T3 (pl) |
| PL (1) | PL3825695T3 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2694976A2 (en) * | 2011-04-06 | 2014-02-12 | Stallergenes S.A. | Biomarkers of immunotherapy efficacy |
| WO2016066770A1 (en) * | 2014-10-29 | 2016-05-06 | Stallergenes | Markers of immune response |
| EP3402899B1 (en) * | 2016-01-13 | 2020-07-22 | Stallergenes | Il-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy |
-
2020
- 2020-10-08 PL PL20200807.4T patent/PL3825695T3/pl unknown
- 2020-10-08 ES ES20200807T patent/ES2972035T3/es active Active
- 2020-10-08 EP EP20200807.4A patent/EP3825695B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3825695A3 (en) | 2021-07-28 |
| ES2972035T3 (es) | 2024-06-10 |
| EP3825695C0 (en) | 2023-12-06 |
| EP3825695A2 (en) | 2021-05-26 |
| EP3825695B1 (en) | 2023-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292727A (en) | Multispecific antibodies | |
| GB201908045D0 (en) | Object analysis | |
| GB201902077D0 (en) | Biomarkers | |
| GB201900677D0 (en) | Biomarkers | |
| GB2596002B (en) | Object analysis | |
| GB201910777D0 (en) | Analytical method | |
| GB202112831D0 (en) | Biomarker | |
| GB201811093D0 (en) | Biomarker | |
| PL3825695T3 (pl) | Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AIT | |
| GB202107813D0 (en) | Biomarker | |
| GB201914183D0 (en) | Biomarker | |
| GB201913846D0 (en) | Biomarker | |
| GB201912154D0 (en) | Biomarker | |
| GB201911078D0 (en) | Biomarker | |
| GB201914096D0 (en) | Cancer Biomarker | |
| GB201901387D0 (en) | Improvements relating to pipeliners | |
| GB2585410B (en) | Analysis | |
| GB201913612D0 (en) | Biomarker | |
| GB201915228D0 (en) | Biomarkers | |
| GB202114656D0 (en) | Biomarker | |
| GB202110365D0 (en) | Biomarker | |
| GB202014824D0 (en) | Biomarker | |
| GB201902070D0 (en) | Biomarkers | |
| PL3822634T3 (pl) | Pasek bioczujnikowy | |
| IL269414A (en) | Rapar for safetyin taneis |